Studies have shown that the predictive value of "clinical diagnoses" of influenza and other respiratory viral infections is low, especially in children. In routine care, pediatricians often resort to clinical diagnoses, even in the absence of robust evidence-based criteria.
Summary
Studies have shown that the predictive value of "clinical diagnoses" of influenza and other respiratory viral infections is low, especially in children. In routine care, pediatricians often resort to clinical diagnoses, even in the absence of robust evidence-based criteria.
We used a dual approach to identify clinical characteristics that may help to differen- We determined pooled odds ratios for the literature analysis and compared these to odds ratios based on the clinical cohort dataset.
This combined analysis suggested significant associations between influenza and fever or headache, as well as between respiratory syncytial virus infection and cough, dyspnea, and wheezing. Similarly, literature and cohort data agreed on significant associations between HMPV infection and cough, as well as adenovirus infection and fever. Importantly, none of the abovementioned features were unique to any particular pathogen but were also observed in association with other respiratory viruses.
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| INTRODUCTION
Influenza and acute respiratory infections (ARI) are major contributors to disease burden in the pediatric age group [1] [2] [3] [4] with highest mortality rates in resource-limited settings. 5, 6 It has been shown that the positive predictive value of a "clinical"
influenza diagnosis in children is as low as 32%. 7 In children in particular, influenza symptoms are often nonspecific, making it difficult to distinguish influenza infection from infection because of other respiratory viruses. 8 The ability to make accurate "clinical diagnoses" is further hampered by the frequent succession of different respiratorys infection during the winter months. To address this question further, we explored which clinical features, according to the published literature, may be associated with ARI due to influenza, respiratory syncytial virus (RSV), human adenovirus (HAdV), human rhinovirus (HRV), human metapneumovirus (HMPV), human bocavirus-1 (HBoV-1), human parainfluenza virus (HPIV), and human coronavirus (HCoV).
We then addressed the same question through analysis of a "real-world" dataset based on a prospective surveillance of 6073 children aged 0 to 18 years, where detailed clinical presentations and virus diagnoses were assessed and documented in all patients, independent from routine care. 10 The objectives of this analysis are as follows: In the first round of review, the following data were extracted independently: (1) study location (country), (2) study design, (3) age range, (4) cohort size/number of subjects, (5) sampling and laboratory method, and (6) presenting symptoms including respiratory and extrarespiratory symptoms. Full-text publications were accessed for a second round of review. XM and BR independently reviewed studies against the predefined inclusion and exclusion criteria, and any eligible discrepancy was resolved by discussion among the reviewer team 
| Inception cohort analysis
The literature review was compared to a well-described clinical inception cohort [11] [12] [13] [14] [15] : In summary, the QI program used an unbiased approach where all 19 predefined clinical features were assessed at the point of care, and all 8 viruses were tested in all ILI patients.
| Comparative analysis
The comparative statistical analysis was performed using R with the Metaphor Package software. 20 Clinical features associated with viral pathogens were determined independently using pooled odds ratios (pOR), with 95% confidence intervals (CI) for the literature review Random effect models for meta-analysis were applied. 20 Heterogeneity testing was done using I 2 statistics. I 2 values <25% were considered low, 25% to 75% as moderate, and values >75% indicated high levels of heterogeneity. 21 Publication bias was assessed using funnel plots. A symmetrical plot indicates a lack of publication bias. 22 For each used OR calculation, we estimated the exact CI using the mid-p method. 23 3 | RESULTS
| Characteristics of the literature review
The initial Medline search yielded 1861 potentially relevant publications. After manual screening of all titles and abstracts, 666 publications were relevant to the topic. Of these, 47 eligible publications were included into the final analysis according to the predefined inclusion and exclusion criteria ( Figure 1 ).
The 47 eligible publications are listed in Table 1 . In clinical practice, fever is often considered a hallmark of influenza disease, whereas wheezing is viewed as "typical" for RSV infections.
Therefore, we studied these clinical associations in detail in the pub- I 2 = 66%) (Figures 2A and 4A ). As evident from detailed literature analysis, most studies agreed on a positive correlation, with 1 exception. 66 No evidence of publication bias was observed. There was no significant association in the meta-analysis between fever and RSV (pOR 
| Clinical associations across all types of respiratory infection
Associations with fever or wheezing however are neither unique to influenza nor to RSV. When we studied the meta-analyses across all 8 types of respiratory viral infection, multiple overlapping associations were easily identified for different types of respiratory viral infections ( Figure 4A ). In fact, most associations were shared across multiple types of viral infection, and no clinical feature stood out as unique to any specific type of infection.
In addition to influenza, fever was also significantly associated with HMPV (pOR = 1. 
| New associations revealed in the inception cohort (COH)
The same clinical features were now tested in the clinical cohort ( Figure 4B ). The most striking difference was that associations in the COH dataset yielded narrower CI compared to the LIT dataset.
Several new (positive and negative) associations were revealed in the COH dataset that were not previously observed in the meta-anal- Overall, literature data on RSV and influenza (and to a lesser degree, HMPV) seemed more readily available than literature on other respiratory viruses, which remain understudied in children. With the advent of new vaccines and antivirals against various respiratory viruses however, it will soon become critical to distinguish respiratory viral infections and to study the associated disease burden, including in the acute care setting.
The individual studies in our meta-analysis showed high levels of heterogeneity, especially with regards to inclusion criteria and/or cutoff criteria for specific symptoms such as fever and hypoxia. For instance, 7 studies used a hypoxia definition of oxygen saturation <90% while 2 studies used higher thresholds of <92% 29 and <95%
60
. Similarly, 11 studies defined fever as body temperature To avoid observer bias in the inception cohort, a trained QI team elicited these symptoms accurately in all patients, regardless of age.
In clinical routine care in most settings, it will not be feasible to obtain virus diagnostics on the 8 most common respiratory viral pathogens in all patients with ILI, as was the case in this inception cohort. infection is dominated by systemic symptoms such as fever, myalgia, chills, headache, malaise, and anorexia. 74 It also suggests that the onset of RSV infections is associated with rhinorrhea, cough, and wheezing, sometimes concomitant with a low-grade fever. 75 Testing should be encouraged to prevent unnecessary prescriptions of antivirals in "similar-looking" noninfluenza cases, where neuraminidase inhibitors would be ineffective. 81, 82 Methodologically, prospective data collection may be more effec- BS supervised the laboratory work and contributed significantly to the writing of the manuscript. TC conducted the statistical analysis and contributed to the writing of the manuscript. JR supported the laboratory work and contributed significantly to the writing of the manuscript. MA as a key member of the QI staff contributed to the clinical data collection and to the writing of the manuscript. All authors have seen and approved the final version of the manuscript.
